[
  {
    "ts": "2025-12-03T15:11:31+00:00",
    "headline": "How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story",
    "summary": "Harrow, Inc. has secured a key win as CVS’s pharmacy benefit manager replaced Xiidra with Harrow’s dry eye drug Vevye on its Tier 1 formulary, and the company recently presented at BTIG Ophthalmology Day and the Piper Sandler Healthcare Conference in New York. This formulary upgrade at the largest U.S. PBM could materially improve patient access and prescription volumes for Vevye, reinforcing Harrow’s position in branded ophthalmic pharmaceuticals. We’ll now examine how CVS elevating Vevye...",
    "url": "https://finance.yahoo.com/news/cvs-elevating-vevye-tier-1-151131244.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "9360d757-549f-3e9f-8a1b-0dc8296e3938",
      "content": {
        "id": "9360d757-549f-3e9f-8a1b-0dc8296e3938",
        "contentType": "STORY",
        "title": "How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story",
        "description": "",
        "summary": "Harrow, Inc. has secured a key win as CVS’s pharmacy benefit manager replaced Xiidra with Harrow’s dry eye drug Vevye on its Tier 1 formulary, and the company recently presented at BTIG Ophthalmology Day and the Piper Sandler Healthcare Conference in New York. This formulary upgrade at the largest U.S. PBM could materially improve patient access and prescription volumes for Vevye, reinforcing Harrow’s position in branded ophthalmic pharmaceuticals. We’ll now examine how CVS elevating Vevye...",
        "pubDate": "2025-12-03T15:11:31Z",
        "displayTime": "2025-12-03T15:11:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zGlsZQabpZKiecAhuIM4vQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/whFiaQBgqA5L2OMhKv37Ig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-elevating-vevye-tier-1-151131244.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-elevating-vevye-tier-1-151131244.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HROW"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-03T14:00:04+00:00",
    "headline": "CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finance.yahoo.com/news/cvs-health-corporation-cvs-attracting-140004021.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f142b028-7a8f-3d62-8dca-ed082a8b08e0",
      "content": {
        "id": "f142b028-7a8f-3d62-8dca-ed082a8b08e0",
        "contentType": "STORY",
        "title": "CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know",
        "description": "",
        "summary": "Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
        "pubDate": "2025-12-03T14:00:04Z",
        "displayTime": "2025-12-03T14:00:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248",
          "originalWidth": 900,
          "originalHeight": 467,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EqfP7bv9QEr5Eo0h619oww--~B/aD00Njc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248.cf.webp",
              "width": 900,
              "height": 467,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vJLygzZiYik0.mXQcVdmSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-corporation-cvs-attracting-140004021.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-corporation-cvs-attracting-140004021.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-03T16:24:27+00:00",
    "headline": "CVS Health Still Long Crowded, Well-Liked Amid Investor Expectations for Upside, UBS Says",
    "summary": "CVS Health (CVS) is still \"long crowded and well-liked\" by investors ahead of next week's investor e",
    "url": "https://finance.yahoo.com/news/cvs-health-still-long-crowded-162427678.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "7fa20009-f3b7-3143-897a-0b39ed9e4886",
      "content": {
        "id": "7fa20009-f3b7-3143-897a-0b39ed9e4886",
        "contentType": "STORY",
        "title": "CVS Health Still Long Crowded, Well-Liked Amid Investor Expectations for Upside, UBS Says",
        "description": "",
        "summary": "CVS Health (CVS) is still \"long crowded and well-liked\" by investors ahead of next week's investor e",
        "pubDate": "2025-12-03T16:24:27Z",
        "displayTime": "2025-12-03T16:24:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-still-long-crowded-162427678.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-still-long-crowded-162427678.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]